# Aligos Therapeutics, Inc.: Form 8-K, filed Sep 7, 2023

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2023-09-07
- Accepted by EDGAR: Sep 7, 2023, 16:01 ET
- Period: 2023-09-05
- Accession: 0001193125-23-230611
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312523230611/d549184d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312523230611/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312523230611/d549184d8k.htm

Filed Sep 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-230611. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
